In the News

1839 News Items found
Intern Kathleen Navas
Commitment to Education and Mentoring: How Memorial Sloan Kettering Continued Summer Internships During the Pandemic
While numerous summer student internships were cancelled this year due to the pandemic, MSK quickly modified many of our summer student programs to enroll more than 300 interns from around the world – both virtually and in-person.
Lisa M. DeAngelis, MD, Physician-in-Chief and Chief Medical Officer of MSK
MSK Physician-In-Chief: The Time is Now for Routine Cancer Screenings
Cancer screenings are essential. MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared why cancer care screenings are critical during an interview with PBS Metrofocus.
Finding
Surgeon William Jarnagin
Experimental Blood Test Uses EVP Proteins to Detect Cancer
Researchers report a new method that may enable detection of a number of different types of cancer in the early stages.
Q&A
Jeffrey Drebin, Chair of the Department of Surgery at MSK
Creating a Safe Space for Cancer Surgery at MSK: 5 Things to Know
MSK's Chair of the Department of Surgery discusses what people need to know about rescheduling treatment and what we're doing to keep you safe.
Craig B. Thompson, MD, President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center
MSK’s Craig B. Thompson, MD, Joins New York Jobs CEO Council
MSK President and CEO, Craig B. Thompson, MD, has been named a founding member of the New York Jobs CEO Council. Dr. Thompson joins CEOs from 27 of the largest employers in New York in the new CEO-led, action-oriented coalition.
Crain’s Notable in Health Care in NYC List
MSK Leaders Recognized in Crain’s New York Business 2020 Notable in Healthcare List
The third-annual Crain’s New York Business Notable in Healthcare list celebrates outstanding individuals in the healthcare community within the New York metropolitan area, and honors their professional, civic, and philanthropic achievements.
Large International Study Pinpoints Impact of TP53 Gene Mutations on Blood Cancer Severity
Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering.
Joan Massagué, PhD
Spotlight Speaker: SKI Director, Joan Massagué, PhD
SKI Director, Joan Massagué, PhD, is an internationally renowned cancer biologist and leading researcher in the study of cancer metastasis. He is featured in the July 29 MSK Science Spotlight.
Alexander Rudensky, PhD
Shining a Spotlight on Pioneering Immunologist, Alexander Rudensky, PhD
The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD.
Dr. Lisa DeAngelis
Cancer Is Not Going Away During COVID-19: Physician-in-Chief Lisa DeAngelis Shares Why Patients Need to Get Back to the Clinic
Cancer institutions need to be vigilant in their approach to getting patients safely back to the clinic so they don’t further delay life-saving care.